What is the size of the Cardiac Diagnostics Market?
According to 6Wresearch internal database and industry insights,Global Cardiac Diagnostics Market was exhibited atUSD 9.9 billion in 2024 and is projected to reachUSD 15 billion by 2031, growing at aCAGR of 6.7% during the forecast period 2025–2031.
Due to the increasing prevalence of cardiovascular diseases, rising awareness for early detection, and technological advances in non-invasive diagnostic tools, the market is anticipated for steady growth in the coming years.
Key Growth Drivers of the Cardiac Diagnostics Market
- Growing incidence of heart disease and related risk factors
- Technological innovations in imaging and wearable diagnostics
- Increased public and private healthcare spending
- Rising demand for early diagnosis and preventive care
- Adoption of AI and telehealth platforms for cardiac monitoring
Cardiac Diagnostics Market Trends
The cardiac diagnostics market is evolving with increasing integration of AI in ECG and echocardiogram interpretation, enabling faster and more accurate diagnosis. Portable and wearable cardiac monitors are gaining popularity, especially for outpatient and home care settings. Also, the trend of personalized diagnostics based on genomic and biomarker data are also becoming more prominent. Together, all these trends are contributing in the expansion of the market.
Emerging Developments in the Cardiac Diagnostics Market
Cardiac diagnostic market is developing with the time as like handheld ultrasound, remote ECG patch monitoring, and cloud-based diagnostic platforms are transforming how cardiac care is delivered. Investment in point-of-care testing and digital platforms is improving accessibility in underserved regions. Further, the collaborations between healthcare and tech firms are accelerating AI-enabled diagnostic tools.
Leading Companies in the Cardiac Diagnostics Market
- GE HealthCare
- Philips Healthcare
- Siemens Healthineers
- F. Hoffmann-La Roche Ltd
- Abbott Laboratories
- Canon Medical Systems Corporation
- Medtronic
- Cardioline SpA
- BPL Medical Technologies
- Hill-Rom (Welch Allyn)
How big is the Cardiac Diagnostics Market : FAQs
The cardiac diagnostics market was estimated at USD 9.9 billion in 2024 and is projected to reach USD 15 billion by 2031.
Growth of market is driven by rising cardiovascular disease cases, early detection demand, and tech-enabled diagnostics.
AI integration, wearable monitors, and portable diagnostics are key trends in this space.
GE HealthCare, Philips, Siemens, Abbott, and Roche are major companies in the industry.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com